Astrana Health, Inc. (ASTH)

Astrana Health Stock Forecast

Stock Price Forecast

The 6 analysts that cover Astrana Health stock have a consensus rating of "Strong Buy" and an average price target of $34, which forecasts a 40.32% increase in the stock price over the next year. The lowest target is $26 and the highest is $40.

Price Target: $34 (+40.32%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$26	$34	$37	$40
Change	+7.30%	+40.32%	+52.70%	+65.08%

Analyst Ratings

The average analyst rating for Astrana Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	5	6	7	7	7	5
Buy	1	1	1	1	1	0
Hold	2	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	9	9	9	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jailendra Singh Truist Securities	Truist Securities	Strong Buy Maintains $37 → $38	Strong Buy	Maintains	$37 → $38	+56.83%	Mar 13, 2026
David Larsen BTIG	BTIG	Strong Buy Maintains $45 → $40	Strong Buy	Maintains	$45 → $40	+65.08%	Feb 2, 2026
Matthew Shea Needham	Needham	Strong Buy Initiates $28	Strong Buy	Initiates	$28	+15.56%	Dec 12, 2025
Jack Slevin Jefferies	Jefferies	Strong Buy Maintains $44 → $37	Strong Buy	Maintains	$44 → $37	+52.70%	Nov 25, 2025
Andrew Mok Barclays	Barclays	Hold Maintains $36 → $26	Hold	Maintains	$36 → $26	+7.30%	Nov 24, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

4.05B

Increased by 27.32%

from 3.18B

Revenue Next Year

4.49B

Increased by 10.84%

from 4.05B

EPS This Year

1.26

Increased by 175.42%

from 0.46

EPS Next Year

1.91

Increased by 51.46%

from 1.26

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	773.92M	1.14B	1.39B	2.03B	3.18B	4.05B	4.49B
Revenue Growth	12.62%	47.84%	21.19%	46.72%	56.39%	27.32%	10.84%
EPS	1.52	0.99	1.29	0.90	0.46	1.26	1.91
EPS Growth	50.50%	-34.87%	30.30%	-30.23%	-49.09%	175.42%	51.46%
Forward PE	-	-	-	-	-	19.20	12.68
No. Analysts	-	-	-	-	-	13	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	4.3B	4.8B
Avg	4.1B	4.5B
Low	3.7B	4.1B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	35.1%	18.6%
Avg	27.3%	10.8%
Low	17.8%	1.5%

EPS Forecast

EPS	2026	2027
High	2.08	2.61
Avg	1.26	1.91
Low	0.03	0.59

EPS Growth

EPS Growth	2026	2027
High	353.7%	107.2%
Avg	175.4%	51.5%
Low	-93.6%	-53.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.